glp 1 efficacy Q&A: Long-term success of GLP-1 therapies hinges on more than just a prescription GLP-1 comparison… but make it

However, none have demonstrated clinically meaningful cardiorenal improvements

Oral Wegovy (semaglutide) has demonstrated a 15% weight-loss average in clinical trials, while Foundayo (orforglipron) has helped people lose approximately 12% to 14% of their starting weight

Patients receive personalized care and ongoing medical support, with treatment options designed for long-term weight management

Low-Energy-Density Diets Are Associated with High Diet Quality in Adults in the United States. Journal of the American Dietetic Association 106 (8): 117280

The 60-Minute GLP-1 Weekly Prep Schedule GLP-1 users often have lower energy levels, especially during the first months or after dose adjustments